China Risun Group (SEHK:1907) just released its half year 2026 earnings, reporting sales of CNY 21,855.86 million and net income of CNY 203.97 million, along with higher basic and diluted earnings per share.
China Risun Group's share price closed at HK$1.93 after the earnings release, with a 1-day share price return of 1.31%. However, the stock is still down 22.8% on a 90-day share price basis and has recorded a 22.67% decline in total shareholder return over the past year. This indicates that recent pressure has eased only slightly despite the stronger half year results.
Scan how China Risun Group compares with other materially focused businesses facing similar sentiment shifts by reviewing the hand picked right now.
China Risun Group has a sharply better half year, but a share price that is still well below where it was a few months ago. Does this move reflect improving fundamentals, or just a short-term shift in sentiment as valuation resets?
Advertisement
Preferred P/E of 29.5x: Is it justified for China Risun Group?
On valuation, China Risun Group trades on a P/E ratio of 29.5x, while the last close sits at HK$1.93. Compared with both its Hong Kong Chemicals peers and an estimated fair multiple, that level points to a rich pricing of current earnings.
The P/E ratio compares the share price to earnings per share. For a materials and chemicals producer like China Risun Group, this metric gives a quick sense of how much investors are paying for each unit of reported profit. A higher P/E often reflects confidence in future profit growth or the perceived quality and stability of those earnings.
Here that premium is clear. Management has only recently returned the group to profitability and earnings are expected to grow at 48.25% per year according to the provided forecasts. The market seems to be pricing in these projections aggressively, given the P/E sits well above both the Hong Kong Chemicals industry average of 9.6x and the peer average of 6.5x. The estimated fair P/E of 16.7x is also well below the current 29.5x. This suggests the multiple could drift closer to that level if expectations cool or results track closer to more typical sector outcomes.
For investors who want a structured view of how this could evolve, including the fair ratio estimate the SWS framework uses, it is worth reviewing the dedicated fair ratio workup for China Risun Group, starting with the .
Result: Price-to-earnings of 29.5x (OVERVALUED)
Still, the long slide in China Risun Group's 1 year and 5 year total returns, along with a low value score, could easily cap any sentiment reset.
Another View on China Risun Group's Value
The P/E screen paints China Risun Group as expensive, yet the SWS DCF model points in the opposite direction. With an estimated value around HK$42.89 per share versus the current HK$1.93 price, the stock screens as heavily undervalued. Which lens should carry more weight for you right now?
1907 Discounted Cash Flow as at Sep 2026
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( ). We show the entire calculation in full. You can track the result in your or and be alerted when this changes, or use our stock screener to discover . If you we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Sentiment looks split on China Risun Group, which is exactly when fresh eyes matter most. Move quickly, review the numbers yourself and weigh both the upside and the downside using the .
Looking for more China Risun Group style investment ideas?
Do not stop with China Risun Group. Broaden your watchlist today with focused stock ideas built from hard numbers, not headlines, so you are not late to the next move.
Target quality at a discount by reviewing the that filters for strong businesses pricing in cautious expectations.
Strengthen your downside protection by scanning the tuned for companies with more resilient profiles.
Hunt for underfollowed potential by checking the where fundamentals, not popularity, do the talking.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics. Explore Now for Free
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
(0)Comments